Bioadhesive properties of Gantrez nanoparticles

Area of Science:

• Materials Science
• Nanotechnology
• Pharmaceutics

Background:

• Bioadhesive nanoparticles offer a promising strategy for oral drug delivery, particularly for poorly soluble drugs.
• Gantrez nanoparticles have been investigated for their potential as drug carriers.
• Understanding nanoparticle adhesion is crucial for optimizing oral drug delivery systems.

Purpose of the Study:

• To evaluate the bioadhesive potential of Gantrez nanoparticles for oral drug delivery.
• To investigate the effect of nanoparticle formulation (nanoparticles vs. solubilized form) on adhesion.
• To assess the impact of cross-linking and surface coating on nanoparticle adhesion and distribution in the gastrointestinal tract.

Main Methods:

• Fluorescently labeling Gantrez nanoparticles with rhodamine B isothiocyanate.
• Comparing the adhesive potential of nanoparticle-folded Gantrez versus solubilized Gantrez.
• Investigating the effect of cross-linking with 1,3-diaminopropane on nanoparticle stability and adhesion.
• Coating nanoparticles with gelatin and bovine serum albumin (BSA) and evaluating their gastrointestinal tract distribution.

Main Results:

• Gantrez nanoparticles exhibited stronger adhesion than solubilized Gantrez.
• Nanoparticles showed a preference for the upper gastrointestinal tract, with peak adhesion at 30 minutes post-administration.
• Cross-linking with 1,3-diaminopropane enhanced nanoparticle stability and modulated adhesion duration.
• Gelatin coating reduced mucosal interaction, while BSA coating resulted in significant stomach mucosa tropism.

Conclusions:

• Gantrez nanoparticles demonstrate significant bioadhesive properties suitable for oral drug delivery.
• Cross-linking and protein coating (BSA) are effective strategies to control nanoparticle adhesion and gastrointestinal distribution.
• BSA-coated nanoparticles show potential for targeted stomach delivery.